Device useful for excessive menstrual bleeding

Key points
- A tiny device that is placed inside the uterus and releases the hormone levonorgestrel is an effective treatment for excessive menstrual bleeding, a problem called menorrhagia, new research shows.
- The device, which goes by the trade name Mirena, is already approved for use as a contraceptive.
- The new findings, which appear in the journal Obstetrics and Gynecology, are based on a study of 59 women with menorrhagia who were treated with Mirena or underwent surgery to remove the lining of the uterus-the part that bleeds.
- Blood loss, based on the number of tampons or pads used and their degree of soiling, was determined by the patients using pictorial charts.
A tiny device that is placed inside the uterus and releases the hormone levonorgestrel is an effective treatment for excessive menstrual bleeding, a problem called menorrhagia, new research shows.
The device, which goes by the trade name Mirena, is already approved for use as a contraceptive. After being inserted by a physician, Mirena can provide birth control for months or years as needed.
The new findings, which appear in the journal Obstetrics and Gynecology, are based on a study of 59 women with menorrhagia who were treated with Mirena or underwent surgery to remove the lining of the uterus-the part that bleeds.
Blood loss, based on the number of tampons or pads used and their degree of soiling, was determined by the patients using pictorial charts.
Nineteen of 30 women in the Mirena group and 22 of 29 in the surgery group completed the 3-year follow-up period.
Patients in both groups experienced a dramatic and comparable drop in blood loss, lead author Dr. Ilkka Rauramo, from The Finnish Medical Society Duodecim in Helsinki, and colleagues note.
"On the basis of our data and the literature, strong evidence exists to suggest that (Mirena) should be considered the first-line treatment for...menorrhagia because it is easy to insert, has a sustained effect, provides contraception, may reduce the need for surgery, and is cost-effective and well tolerated," the authors conclude.
Mirena is marketed by Berlin-based Schering AG, which sponsored the current study.
SOURCE: Obstetrics and Gynecology, December 2004.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Women's Health →
NewsHysterectomy for bleeding may cause urinary woes
Women who undergo a hysterectomy to treat heavy menstrual bleeding may have higher rates of urinary tract problems over the long term than those treated with the contraceptive device Mirena, a new study suggests. The…
5 March 2010
NewsAcupuncture may relieve menstrual cramps
Acupuncture may be helpful in alleviating menstrual cramps, which affects up to half of all young women, an extensive review of past studies has found. In a review of 27 studies that involved nearly 3,000 women,…
19 February 2010
NewsNSAIDs may beat acetaminophen for menstrual cramps
The class of painkillers that includes ibuprofen and naproxen seems to work well against menstrual cramps, and may be more effective than acetaminophen, a new research review suggests. The medications, collectively…




